X0508 4 2023-07-14 0000748592 Eterna Therapeutics Inc. ERNA 0001277280 WAGNER RICHARD W C/O ETERNA THERAPEUTICS INC. 1035 CAMBRIDGE STREET, SUITE 18A CAMBRIDGE MA 02141 true false 6.0% Senior Convertible Promissory Notes due 2028 2.86 2023-07-13 4 P 0 120000 120000 A 2023-07-14 2028-07-14 Common Stock 41958 120000 D Warrants (right to buy) 2.61 2023-07-13 4 P 0 83916 0.125 A 2023-07-14 2028-07-14 Common Stock 83916 83916 D The reporting person entered into a Securities Purchase Agreement with the Issuer on July 13, 2023, pursuant to which, on July 14, 2023, the reporting person acquired $120,000 principal amount of the Issuer's 6.0% Senior Convertible Promissory Notes due July 2028 (the "Notes") and (ii) 83,916 warrants, each exercisable to purchase one share of the Company's common stock, par value $0.005 per share ("Common Stock"), at an exercise price of $2.61 per share (the "Warrants"), representing 200% of the number of shares of Common Stock issuable upon conversion of the Notes immediately after the issuance thereof. The conversion price for each Note included $0.25 ($0.125 for each Warrant share) in accordance with Nasdaq rules. /s/ Richard Wagner 2023-07-18